Who
Wendy E. Lane
Director
Company insider
Files Form 4 as: Director, Masimo; Director, Verisk Analytics; Director, Envestnet; Director, Willis Towers Watson Public Limited; Director, Corelogic; Director, Msci; Director, Labcorp Holdings.
In numbers
- Trades disclosed
- 173
- Buys
- 3
- Sells
- 15
- Bought
- $400K
- Sold
- $1.6M
- Companies
- 7
- Companies where not an officer
- 7
- First trade
- 3 Jan 2006
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | MasimoMedical Devices | SEC FORM 4 Code D | $469K2,608 at $180.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code D | —1,119 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimooption or derivative | SEC FORM 4 Code D | —1,119 | filing |
| 10 Jun 2026filed 12 Jun 2026 | Masimo | SEC FORM 4 Code D | $469K2,608 at $180.00 | filing |
| 29 Apr 2026filed 5 May 2026 | MasimoMedical Devices | SEC FORM 4 Code M | —1,225 at $0.00 | filing |
| 29 Apr 2026filed 5 May 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code M | —1,225 at $0.00 | filing |
| 29 Apr 2026filed 5 May 2026 | Masimooption or derivative | SEC FORM 4 Code M | —1,225 at $0.00 | filing |
| 29 Apr 2026filed 5 May 2026 | Masimo | SEC FORM 4 Code M | —1,225 at $0.00 | filing |
| 23 Apr 2026filed 5 May 2026 | Masimooption or derivative · Medical Devices | SEC FORM 4 Code A | $200K1,119 at $178.71 | filing |
| 23 Apr 2026filed 5 May 2026 | Masimooption or derivative | SEC FORM 4 Code A | $200K1,119 at $178.71 | filing |
| 29 Apr 2025filed 2 May 2025 | Masimooption or derivative | SEC FORM 4 Code M | —1,383 at $0.00 | filing |
| 29 Apr 2025filed 2 May 2025 | Masimooption or derivative | SEC FORM 4 Code A | —1,225 at $0.00 | filing |
| 29 Apr 2025filed 2 May 2025 | Masimo | SEC FORM 4 Code M | —1,383 at $0.00 | filing |
| 16 Oct 2024filed 18 Oct 2024 | Masimooption or derivative | SEC FORM 4 Code A | —1,383 at $0.00 | filing |
| 2 Aug 2024filed 5 Aug 2024 | VRSK Verisk AnalyticsExchanges & fin. data | SEC FORM 4 Bought | $158K600 at $263.64 | filing |
| 15 May 2024filed 20 May 2024 | VRSK Verisk AnalyticsExchanges & fin. data | SEC FORM 4 Code A | —847 at $0.00 | filing |
| 29 Feb 2024filed 4 Mar 2024 | Envestnet | SEC FORM 4 Code A | —3,457 at $0.00 | filing |
| 17 May 2023filed 24 May 2023 | VRSK Verisk AnalyticsExchanges & fin. data | SEC FORM 4 Code A | —958 at $0.00 | filing |
| 8 May 2023filed 9 May 2023 | VRSK Verisk AnalyticsExchanges & fin. data | SEC FORM 4 Bought | $218K1,037 at $209.78 | filing |
| 18 Apr 2023filed 20 Apr 2023 | Envestnet | SEC FORM 4 Code A | —1,534 at $0.00 | filing |
News
Labcorp Holdings Inc. (NYSE:LH) Shares to Pay Quarterly Dividend of $0.72LH · dailypolitical.com · 21 Oct 2026Analyzing Verisk Analytics (NASDAQ:VRSK) and Franklin Covey (NYSE:FC)VRSK · tickerreport.com · 20 Oct 2026Labcorp To Buy Myriad Genetics' Prenatal Testing Business For $210 MlnLH · finanzen.ch · 20 Oct 2026Labcorp To Acquire BioReference Health Assets; OPKO Shares Rise 7.35%LH · rttnews.com · 15 Oct 2026Verisk Analytics (VRSK): Is Its Insurance-Data Moat Wide Enough to Justify the Price?VRSK · insidermonkey.com · 9 Oct 2026
0 headlines in the last 90 days name Wendy E. Lane; 5 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.